A Biosocial Lens on Comprehensive Services for COVID-19 in Immokalee, FL
Jude Beauchamp, MD, MMSc ‘17, started working with Partners in Health in 2010 as a primary care physician at Bon Sauveur Hospital in Cange, providing general care and organizing community/outreach activities (mobile clinics). In 2021, he was promoted to lead the HIV/TB/DR-TB program. He provided holistic care to both inpatients and outpatients. He supported the National Tuberculosis Program of the Ministry of Health (MOH) through training health care providers from across Haiti in TB and MDR-TB care. His interest in both innovation and research to improve the quality of care led him to incorporate quality improvement research-based interventions into the TB program. In 2017, Jude also led the Linkages Across the Continuum of HIV Services for Key Populations Affected by HIV (LINKAGES) project for Zanmi aimed to make HIV services accessible to marginalized key populations (Men who have Sex with Men (MSM), Female Sex Workers (FSWs)) through prevention, education, and clinical care. His passion for health system strengthening made Jude join PIH-Liberia in 2018, implementing Global Fund grants to improve the quality of care for patients with drug-resistant TB (DRTB) in collaboration with the Liberia National Leprosy and Tuberculosis Control Program (NLTCP). With the COVID-19 pandemic, Jude also served as COVID-19 co-lead, helping coordinate/implement Partners In Health (PIH) Liberia COVID-19 response, providing technical support and resources to the Liberia Incident Management System (IMS). Over the last spring, Jude has transitioned to the USA and recently joined the PIH-US team in Immokalee, Florida, as Senior Project Lead. Jude graduated from the Master of Medical Sciences in Global Health Delivery program in 2017.
Carole Mitnick, ScD, is Professor of Global Health & Social Medicine at Harvard Medical School (HMS) and Associate Epidemiologist in the Division of Global Health Equity at Brigham & Women’s Hospital. She has 25 years of experience in programmatic support, research (observational and experimental), policy, and advocacy related to increased access to high-quality, appropriate treatment for TB, especially for drug-resistant TB. Dr. Mitnick collaborates with Partners In Health, specifically in Peru, Haiti, Kazakhstan, and Lesotho. In addition to teaching courses at HMS and giving lectures at other institutions, Dr. Mitnick enthusiastically mentors trainees in global health. She is currently the co-PI of the endTB and endTB-Q trials, two multi-country, Phase III, randomized, controlled, clinical trials of all-oral, shortened, novel regimens for rifampin-resistant TB.